Impact of elotuzumab treatment on pain and health-related quality of life in patients with relapsed or refractory multiple myeloma: results from the ELOQUENT-2 study
- David Cella
- , Jan McKendrick
- , Amber Kudlac
- , Antonio Palumbo
- , Abderrahim Oukessou
- , Ravi Vij
- , Teresa Zyczynski
- , Catherine Davis
Research output: Contribution to journal › Article › peer-review
17
Link opens in a new tab
Scopus
citations